title: Total parenteral nutrition in poor prognosis gestational trophoblastic disease.
abstract: From 1978 through 1984, 35 women received therapy for poor prognosis gestational trophoblastic disease (GTD) at Duke University Medical Center. Total parenteral nutrition (TPN) was utilized in nine patients (26%) for reasons including inadequate oral intake, nutritional depletion, and/or bone marrow suppression. Overall survival with follow-up ranging from 12 to 78 months was 88% for the TPN group and 70% for the non-TPN group (P = 0.38). Median duration of TPN therapy was 4 weeks (2-46 weeks). Intensity of therapy was comparable between the groups. Median weight gain of 0.15 kg/week for the TPN group was significantly greater than the 0.18/kg/week weight loss in the non-TPN group (P less than 0.001). Severe nutritional depletion represented by both low serum albumin (less than or equal to 2.5 gm/dl) and weight loss greater than or equal to 10% had a higher mortality rate than when only one of these factors existed (P = 0.006). Future studies need to further define the proper role of TPN in patients with poor prognosis GTD especially in those with severe nutritional deficits.
authors.affiliation: Duke University Medical Center, Department of Obstetrics and Gynecology, Durham, North Carolina 27710.
authors.forename: L C
authors.initials: LC
authors.lastname: Bandy
authors.forename: N
authors.initials: N
authors.lastname: Chin
authors.forename: J T
authors.initials: JT
authors.lastname: Soper
authors.forename: J P
authors.initials: JP
authors.lastname: Grant
authors.forename: C B
authors.initials: CB
authors.lastname: Hammond
mesh_terms: D000293:Adolescent; D000328:Adult; D001835:Body Weight; D005260:Female; D006801:Humans; D008875:Middle Aged; D010289:Parenteral Nutrition, Total; D011247:Pregnancy; D011379:Prognosis; D014328:Trophoblastic Neoplasms / Q000401:mortality / Q000628:therapy*; D014594:Uterine Neoplasms / Q000628:therapy*